[Cardio-circulatory arrest with mifepristone sulprostone combination for pregnancy interruption].
Sorbette
F
F
Delay
M
M
Genestal
M
M
Jorda
M F
MF
Carrie
D
D
Montastruc
J L
JL
Catala
B
B
Bernadet
P
P
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000032:Abortion, Therapeutic / Q000009:adverse effects; D015232:Dinoprostone / Q000009:adverse effects / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D005260:Female; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011247:Pregnancy
D000020:Abortifacient Agents, Nonsteroidal; D015735:Mifepristone; C016767:sulprostone; D015232:Dinoprostone
Arrêt cardio-circulatoire au cours de l'association mifépristone-sulprostone pour interruption de grossesse.